Skip to content
Peptigraph home

Sermorelin vs HGH: What the Research Shows

Sermorelin and HGH side by side: what they are, how they are regulated and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
GHRH analogCompounded by prescriptionSermorelinGHRH analog once FDA-approved as Geref and since discontinued; in an uncontrolled pediatric study mean height velocity rose from 4.1 to 8.0 cm/yr after 6 months.[16]Growth hormoneRecombinant growth hormoneFDA approved (prescription only)HGHRecombinant human growth hormone, FDA-approved by prescription; in a randomized trial, 4 weeks of supraphysiological dosing did not improve power output or oxygen uptake.[17]Growth hormone
Quick verdict

Where the research points

Summary of studies, not a recommendation

Consider Sermorelin if…

  • you want human data in growth-hormone-deficient children, though uncontrolled: Mean height velocity rose from 4.1 cm/yr at baseline to 8.0 cm/yr at 6 months and 7.2 cm/yr at 12 months (open-label, no control group).[16]

Consider HGH if…

  • you want products with an FDA label: Genotropin (somatropin) is indicated for children with growth failure from inadequate growth hormone secretion[10]
  • you want the option with larger height-velocity gains in children: a sermorelin review reports smaller increases with sermorelin than with somatropin, 30 microg/kg per day each (indirect comparison)[18]
  • you want randomized data in adults with growth hormone deficiency: Within 3 months lean body mass rose 5.09% and body fat fell 10.89%; waist fell 1.42%.[19]

What they have in common

  • Sermorelin's only FDA record is Geref, listed with marketing status Discontinued[20]
Sermorelin is not FDA approved. Both are prohibited in tested sport (WADA). Status labels come from public FDA and WADA records; see the sources below.
Side by side

Spec comparison

Showing 8 of 11 fields where the two differ. Category, PCAC vote, Jul 2026, Evidence strength are the same or both unknown.

FieldSermorelinHGH
ClassGHRH analogRecombinant growth hormone
Also called—GH, growth hormone, generic HGH, IU
FDA statusCompounded by prescriptionFDA approved (prescription only)
WADAProhibited by WADA (S2.2.4)Sermorelin is named as a GHRH analogue in S2.2.4 (growth hormone releasing factors), prohibited at all times.Prohibited by WADA (S2.2.3)Growth hormone and its analogues and fragments are prohibited at all times (S2.2.3).
Anti-doping detection
  • A urine assay detects CJC-1295 and other GHRH analogues at very low concentrations.PMID 35298973
  • Labs expect GHRH analogues like CJC-1295 to be hard to find because of tiny urine concentrations; the study reports no detections in routine anti-doping samples.PMID 34665524
None reportedanti-doping literature, as of 2 Oct 2026
Half-lifeNo published half-life foundPubMed search, 11 Oct 20260.4 hours IV; 3.0 hours subcutaneousintravenous (normal adults); subcutaneous (GHD adults), Genotropin · FDA label (Genotropin)
Human studies we summarised6 human (1 randomized or controlled) of 9 summarised13 human (13 randomized or controlled) of 20 summarised
Typical study doses

Bracketed values are pending a sourced figure. Legal data reflects the regulatory events in our tracker.

Taken together?

Sermorelin and HGH together

People also search for this pair as a stack. The stack page covers timing and interaction questions as they are sourced. Evidence for the combination: 1 published study included both (PMID 10803472).

Open the stack page

A releasing hormone against the hormone itself

A review of sermorelin in children reports that height-velocity increases with sermorelin 30 microg/kg per day, as continuous infusion or 3 divided doses, were less than with once daily somatropin 30 microg/kg.[18]

The same review states that the recommended sermorelin dosage has not been directly compared with somatropin.[18]

A physiology study in normal short children, not a treatment trial, tested how rhGH and/or GHRH administration changed the GH response to GHRH or hexarelin.[15]

In the comparison with young men, subcutaneous GHRH in healthy old men reversed the age-related decreases in GH and IGF-I.[4]

In a study of recombinant GH, lean body mass rose by 5.09% and body fat dropped by 10.89% within 3 months.[19]

A systematic review of GH concluded that claims it enhances physical performance are not supported by the scientific literature.[22]

Approval, schedule and sport rules

Drugs@FDA lists sermorelin only as a discontinued product, GEREF.[20]

Active malignancy is on the somatropin label's contraindication list.[10]

WADA's list has a separate entry for growth hormone, its analogues and fragments, S2.2.3.[1]

Common questions

Is sermorelin the same as HGH?

No. HGH is growth hormone itself, while sermorelin is a growth hormone-releasing hormone analogue. In the children's review, height-velocity gains on sermorelin were less than on somatropin.[18]

Is sermorelin safer than HGH?

The cached sources hold no direct safety comparison. The somatropin label says it is contraindicated in the presence of active malignancy.[10]

Does sermorelin work as well as HGH for anti-aging?

In healthy elderly men, nightly GHRH did not change weight, body mass index, waist to hip ratio or DEXA measures of muscle and fat.[6]

Sources

  1. 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  2. 2An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.Journal of pharmaceutical and biomedical analysis · 2022PMID 35298973Accessed 2 Oct 2026
  3. 3Advances in the detection of growth hormone releasing hormone synthetic analogs.Drug testing and analysis · 2021PMID 34665524Accessed 2 Oct 2026
  4. 4Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.The Journal of clinical endocrinology and metabolism · 1992PMID 1379256Accessed 2 Oct 2026
  5. 5Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.American journal of men's health · 2017PMID 28830317Accessed 2 Oct 2026
  6. 6Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.Metabolism: clinical and experimental · 1997PMID 9005976Accessed 2 Oct 2026
  7. 7PubMed search: (sermorelin[tiab] OR Geref[tiab]) (34 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  8. 8PubMed search: (sermorelin[tiab] OR "GHRH(1-29)"[tiab] OR "GRF(1-29)"[tiab] OR "GHRH 1-29"[tiab]) AND (elderly[tiab] OR aging[tiab] OR "older adults"[tiab] OR adults[tiab]) AND (treatment[tiab] OR therapy[tiab] OR administration[tiab]) (15 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9PubMed search: (sermorelin[tiab] OR Geref[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  10. 10GENOTROPIN (SOMATROPIN) KIT [PFIZER LABORATORIES DIV PFIZER INC]FDA label (Genotropin), DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  11. 11Effect of growth hormone on aging connective tissue in muscle and tendon: gene expression, morphology, and function following immobilization and rehabilitation.Journal of applied physiology (Bethesda, Md. : 1985) · 2014PMID 24235105Accessed 2 Oct 2026
  12. 12Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin.European journal of endocrinology · 2013PMID 23447518Accessed 2 Oct 2026
  13. 13Local administration of growth hormone stimulates tendon collagen synthesis in elderly men.Journal of applied physiology (Bethesda, Md. : 1985) · 2012PMID 22961272Accessed 2 Oct 2026
  14. 14PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR "recombinant growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone therapy"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone administration"[tiab] OR "GH therapy"[tiab] OR "GH treatment"[tiab] OR "GH replacement"[tiab] OR "GH administration"[tiab] OR "growth hormone injection"[tiab] OR "growth hormone injections"[tiab] OR "growth hormone supplementation"[tiab]) AND (sermorelin[tiab] OR Geref[tiab])PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  15. 15The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children.Journal of endocrinological investigation · 2000PMID 10803472Accessed 2 Oct 2026
  16. 16Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.The Journal of clinical endocrinology and metabolism · 1996PMID 8772599Accessed 2 Oct 2026
  17. 17Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes.The Journal of clinical endocrinology and metabolism · 2005PMID 15784718Accessed 2 Oct 2026
  18. 18Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 1999PMID 18031173Accessed 2 Oct 2026
  19. 19Two years of replacement therapy in adults with growth hormone deficiency.Clinical endocrinology · 1997PMID 9404448Accessed 2 Oct 2026
  20. 20Drugs@FDA (openFDA) search: active ingredient "sermorelin"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  21. 21PubMed search: (sermorelin[tiab] OR Geref[tiab] OR "GHRH(1-29)"[tiab] OR "GRF(1-29)"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  22. 22Systematic review: the effects of growth hormone on athletic performance.Annals of internal medicine · 2008PMID 18347346Accessed 2 Oct 2026

Found an error? Report a correction.